Core Viewpoint - A strategic acquisition valued at HKD 3.142 billion is reshaping China's global competitive landscape in the Real World Asset (RWA) tokenization sector [1] Group 1: Strategic Collaboration - The acquisition involves Huajian Medical acquiring approximately 1.848 billion shares of Guofu Quantum, representing 20.31% of the latter's issued share capital, for a total consideration of HKD 3.142 billion [1][4] - This transaction positions Huajian Medical as the largest shareholder of Guofu Quantum, which holds multiple financial licenses in Hong Kong, thereby creating a crucial bridge between traditional finance and Web3 on-chain finance [4][5] - The collaboration is expected to release significant synergies, combining Huajian Medical's leadership in medical testing equipment distribution with Guofu Quantum's comprehensive technology and financial investment platform [5] Group 2: Policy Alignment - The strategic move aligns with national policy directions aimed at fostering technological financial innovation, as outlined in a joint policy document by several Chinese government departments [6][7] - Recent regulatory advancements in Hong Kong, including the implementation of a stablecoin licensing regime, provide a clear compliance framework for RWA token issuance and trading [7] Group 3: Economic Impact - The acquisition's strategic value extends beyond commercial interests, aiming to enhance national innovation and public welfare by improving the liquidity of high-value medical assets through RWA tokenization [8] - The Chinese innovative drug transaction volume is projected to reach USD 60.8 billion in the first half of 2025, reflecting a 129% year-on-year increase, indicating growing global recognition of Chinese innovative drug assets [8] Group 4: Ecosystem Development - Huajian Medical is accelerating the establishment of an RWA exchange platform and on-chain financial ecosystem, including applying for a stablecoin license in the U.S. [9] - The company has initiated a strategic partnership with HashKey to enhance its Ethereum (ETH) treasury strategy, aiming to become a leading entity in ETH reserves within the Hong Kong and global markets [9] - The formation of the "Hong Kong Digital Asset Listed Companies Association" will support Huajian Medical's ecosystem expansion, connecting various stakeholders in the digital asset space [9] Group 5: Industry Growth - The RWA sector is transitioning from concept validation to large-scale application, with total locked value (TVL) in RWA reaching USD 12.5 billion by June 2025, a 124% increase from 2024 [9] - The market size surged from USD 8.6 billion to USD 23 billion in the first half of 2025, marking an increase of over 260% [9] Group 6: Strategic Significance - The partnership between Huajian Medical and Guofu Quantum signifies a critical step for China in the RWA infrastructure sector, potentially securing a first-mover advantage in global competition and enhancing the country's autonomous capabilities in digital financial infrastructure [10]